Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 4 de 4
Filtrer
Plus de filtres











Base de données
Gamme d'année
2.
Practitioner ; 261(1800): 23-7, 2017 01.
Article de Anglais | MEDLINE | ID: mdl-29023082

RÉSUMÉ

More than 200 hereditary cancer susceptibility syndromes have been described, and it is thought that they account for 5-10% of all cancers. Many have dermatological manifestations (usually lesions, occasionally rashes) which frequently precede other systemic pathology. Dermatological signs are usually non-specific and often trivial in appearance, making their significance easy to overlook and a clinical diagnosis challenging. Histological examination is often required to differentiate lesions. They are usually benign and pathologically unrelated to the primary tumours, with the exception of the atypical moles of the dysplastic naevus syndrome, and may present simply as a cosmetic problem for the patient. However, a number of cancer syndromes exhibit an increased risk of developing malignant skin lesions. For instance, Gorlin syndrome (nevoid basal cell carcinoma syndrome) which typically results in the development of multiple basal cell carcinomas, within the first few decades of life. The majority of cancer syndromes with skin signs are inherited in an autosomal dominant pattern demonstrating complete penetrance before the age of 70. Once a cancer syndrome has been diagnosed, the cornerstone of management is frequent surveillance for the early detection and treatment of malignancy. Genetic testing and counselling should be offered to family members.


Sujet(s)
Syndromes néoplasiques héréditaires/diagnostic , Syndromes néoplasiques héréditaires/génétique , Malformations cutanées/diagnostic , Malformations cutanées/génétique , Facteurs âges , Naevomatose basocellulaire/génétique , Femelle , Prédisposition génétique à une maladie , Humains , Mâle , Syndromes néoplasiques héréditaires/complications , Kystes odontogènes/génétique , Facteurs de risque , Peau/anatomopathologie , Malformations cutanées/complications , Tumeurs cutanées/génétique
4.
Practitioner ; 257(1761): 23-7, 2, 2013 May.
Article de Anglais | MEDLINE | ID: mdl-23808128

RÉSUMÉ

Scabies is caused by infestation with a parasitic mite Sarcoptes scabiei var hominis. The itch and rash appear to be largely the result of a delayed (type IV) allergic reaction to the mite, its eggs and excreta. Scabies is spread by a mite transferring to the skin surface of an unaffected person, usually by skin to skin contact with an infested person, but occasionally via contaminated bed linen, clothes or towels. In crusted scabies, mites are also dispersed within shed scales, enabling the condition to be contracted from contaminated surfaces. Patients with classical scabies usually present with an itchy non-specific rash. Often, the history alone can be 0032-6518 virtually diagnostic. An intense itch, affecting all body regions except the head, typically worse at night, appearing to be out of proportion to the physical evidence, with a close contact also itching, should prompt serious consideration of scabies. The generalised hypersensitivity rash consists of erythematous macules and papules with excoriation. Close inspection will reveal burrows usually up to 1 cm in length. The pathognomic sign of scabies is the presence of burrows. The crusted variant of scabies may not be itchy. It is characterised by areas of dry, scaly, hyperkeratotic and crusted skin, particularly on the extremities. Referral to secondary care should be considered in the following cases: diagnostic doubt; patient under two months of age; lack of response to two ourses of different insecticides; crusted scabies; or history suggests a isk of sexually transmitted infection. Outbreaks of scabies in institutions should be referred to the local health protection services.


Sujet(s)
Prurit , Sarcopte scabiei/pathogénicité , Gale , Adolescent , Animaux , Enfant d'âge préscolaire , Femelle , Humains , Insecticides/administration et posologie , Malathion/administration et posologie , Mâle , Perméthrine/administration et posologie , Prurit/étiologie , Prurit/physiopathologie , Gale/diagnostic , Gale/traitement médicamenteux , Gale/physiopathologie , Résultat thérapeutique
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE